Type I Hypersensitivity

DBCOND0030618Immune System Diseases

Type I Hypersensitivity is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Hypersensitivity, Immediate · Immediate Hypersensitivity · IgE-Mediated Hypersensitivity · Atopic Hypersensitivity · Immediate Type Hypersensitivity
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0010854SNOMED CT20671006MedDRA10020762UMLSC0020523

What you can answer from here — as of November 01, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
60Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Type I Hypersensitivity share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In